首页> 外文OA文献 >A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

【2h】

A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

机译：甲氨蝶呤，依托咪酯，地塞米松和pegaspargase夹心放射治疗新诊断的IE-IIE结外自然杀伤/ T细胞淋巴瘤，鼻型的II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Peng-Peng Xu; Jie Xiong; Shu Cheng; Xia Zhao; Chao-Fu Wang; Gang Cai; Hui-Juan Zhong; Heng-Ye Huang; Jia-Yi Chen; Wei-Li Zhao;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 中国南方单中心622例成熟T细胞和自然杀伤细胞淋巴瘤患者中CD30在结外鼻型自然杀伤/T细胞淋巴瘤组织中的表达 [J] . Yanfen Feng, Huilan Rao, Yiyan Lei, 癌症（英文版） . 2018,第005期
2. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type [J] . Peng-Peng Xu, Jie Xiong, Shu Cheng, EBioMedicine . 2017,第4期

机译：甲氨蝶呤，依托泊苷，地塞米松和Pegaspargase夹心放疗的II期研究，用于治疗新诊断的IE到IIE结外型自然杀手/ T细胞淋巴瘤（鼻型）
3. Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma [J] . Wen Wei, Ping Wu, Li Li, Hematology . 2017,第6期

机译：pegaspargase，吉西他滨和奥沙利铂（P-GEMOX）化疗联合放疗在新诊断的IE至IIE期，鼻型结外自然杀伤/ T细胞淋巴瘤中的有效性
4. Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma [J] . Wei Wen, Wu Ping, Li Li, Hematology. . 2017,第6期

机译：Pegaspargase，Gemcitabine和Oxaliplatin（P-Gemox）化疗的有效性与新诊断，阶段，鼻型，外侧天然杀伤/ T细胞淋巴瘤联合放射治疗
5. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. A Phase II Study of Methotrexate Etoposide Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma Nasal-Type [O] . Peng-Peng Xu, Jie Xiong, Shu Cheng, 2017

机译：甲氨蝶呤依托泊苷地塞米松和Pegaspargase夹心放疗的II期研究用于治疗新诊断的IIE期至IIE期结外自然杀手/ T细胞淋巴瘤鼻型
8. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China [O] . Rong Liang, Guang-xun Gao, Jie-ping Chen, 2016

机译：用于新诊断，复发或难治的外杀鼠/ T细胞淋巴瘤，鼻腔类型的甲氨蝶呤，依托泊苷，地塞米松和PEGASPARGASE和PEGASPARGASE化学疗法的第2期研究：中国西北部的多中心试验

A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

著录项

相似文献

相关主题

期刊订阅